Argent BioPharma Limited announced the appointment of Mr. Igor Bluvstein as Chief Financial Officer. Mr. Bluvstein has over 15 years of financial leadership positions in the e-commerce, biotechnology, petrochemical, and medical cannabis industries. He served as the CFO at MDD Group, as Regional CFO at Frutarom Industries Ltd. (acquired by International Flavors & Fragrances Inc. (NYSE: IFF), as the CFO of an e-commerce retailer, as a Financial Controller at Mirland Development Corporation PLC, and as a senior auditor at Ernst & Young Global Ltd. Mr. Bluvstein holds a Bachelor of Arts in accounting and economics from the Open University in Israel.

He is also a Certified Public Accountant (CPA).